Hanmi Pharmaceuticals chairman Lim Sung-ki’s seven grandchildren have become millionaire stockholders following the company’s mega licensing deal, news reports said Sunday.
Hanmi Pharmaceuticals had announced a license agreement of 3.9 billion euros ($4.2 billion) with French drug company Sanofi to develop diabetes drugs on Thursday.
According to market researcher chaebul.com on Friday, the seven grandchildren held stocks worth 109.4 billion won ($94.9 million).
One of the stockowners is Lim’s 12-year-old grandson, who was given the stock as a bonus share. Lim’s six other grandchildren, aged between 7 and 11, have also received stocks through bonus shares or gifts.
Officials from chaebul.com said that the record licensing deal raised the stock value, creating millionaire child stockholders overnight.
(sangyj@heraldcorp.com)
![[KH explains] Will CATL’s Korean push reshape battery alliance with Hyundai, Kia?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/10/09/20241009050092_0.jpg)
